BSE Live
Mar 25, 16:01Prev. Close
2075.65
Open Price
2082.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 25, 15:56Prev. Close
2076.80
Open Price
2092.00
Bid Price (Qty.)
2085.30 (200)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of JB Chemicals and Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 42.00 | 35.07 | 50.29 | 46.71 | 57.85 | |
| Diluted EPS (Rs.) | 41.16 | 34.30 | 49.69 | 46.71 | 57.85 | |
| Cash EPS (Rs.) | 52.61 | 43.73 | 64.73 | 55.94 | 66.57 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 216.94 | 185.98 | 315.65 | 272.21 | 233.75 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 216.94 | 185.98 | 315.65 | 272.21 | 233.75 | |
| Dividend / Share(Rs.) | 15.50 | 12.25 | 17.75 | 16.50 | 16.50 | |
| Revenue from Operations/Share (Rs.) | 239.14 | 212.55 | 372.74 | 283.36 | 244.82 | |
| PBDIT/Share (Rs.) | 67.62 | 58.90 | 87.02 | 70.85 | 86.47 | |
| PBIT/Share (Rs.) | 56.93 | 50.19 | 72.55 | 61.62 | 77.75 | |
| PBT/Share (Rs.) | 56.34 | 47.57 | 68.11 | 60.98 | 76.82 | |
| Net Profit/Share (Rs.) | 41.92 | 35.01 | 50.26 | 46.71 | 57.85 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 28.27 | 27.71 | 23.34 | 25.00 | 35.32 | |
| PBIT Margin (%) | 23.80 | 23.61 | 19.46 | 21.74 | 31.76 | |
| PBT Margin (%) | 23.55 | 22.38 | 18.27 | 21.52 | 31.37 | |
| Net Profit Margin (%) | 17.52 | 16.47 | 13.48 | 16.48 | 23.63 | |
| Return on Networth / Equity (%) | 19.32 | 18.82 | 15.92 | 17.16 | 24.74 | |
| Return on Capital Employed (%) | 24.66 | 25.18 | 18.95 | 21.73 | 31.74 | |
| Return on Assets (%) | 15.61 | 13.88 | 11.20 | 14.22 | 20.31 | |
| Total Debt/Equity (X) | 0.00 | 0.12 | 0.22 | 0.01 | 0.01 | |
| Asset Turnover Ratio (%) | 0.92 | 0.89 | 0.96 | 0.92 | 85.98 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.04 | 2.09 | 2.75 | 3.32 | 4.74 | |
| Quick Ratio (X) | 2.24 | 1.53 | 1.99 | 2.31 | 3.83 | |
| Inventory Turnover Ratio (X) | 7.98 | 1.92 | 2.13 | 1.91 | 6.78 | |
| Dividend Payout Ratio (NP) (%) | 36.32 | 28.89 | 32.80 | 35.32 | 16.42 | |
| Dividend Payout Ratio (CP) (%) | 28.94 | 23.13 | 25.47 | 29.49 | 14.27 | |
| Earnings Retention Ratio (%) | 63.68 | 71.11 | 67.20 | 64.68 | 83.58 | |
| Cash Earnings Retention Ratio (%) | 71.06 | 76.87 | 74.53 | 70.51 | 85.73 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 25,163.36 | 25,876.74 | 15,721.50 | 12,160.10 | 9,688.08 | |
| EV/Net Operating Revenue (X) | 6.76 | 7.84 | 5.45 | 5.55 | 5.12 | |
| EV/EBITDA (X) | 23.90 | 28.31 | 23.35 | 22.21 | 14.50 | |
| MarketCap/Net Operating Revenue (X) | 6.78 | 7.76 | 5.29 | 5.56 | 5.12 | |
| Retention Ratios (%) | 63.67 | 71.10 | 67.19 | 64.67 | 83.57 | |
| Price/BV (X) | 7.48 | 8.87 | 6.24 | 5.79 | 5.36 | |
| Price/Net Operating Revenue | 6.78 | 7.76 | 5.29 | 5.56 | 5.12 | |
| Earnings Yield | 0.03 | 0.02 | 0.03 | 0.03 | 0.05 |
22.03.2026
Sell-on-rise market? SBI Securities sees Nifty under pressure, picks two stocks for the week ahead
16.03.2026
05.03.2026
20.02.2026
20.01.2026
JB Chemicals Consolidated December 2025 Net Sales at Rs 1,064.72 crore, up 10.51% Y-o-Y
20.01.2026
JB Chemicals Standalone December 2025 Net Sales at Rs 990.91 crore, up 8.47% Y-o-Y
17.11.2025
JB Chemicals Consolidated September 2025 Net Sales at Rs 1,084.90 crore, up 8.42% Y-o-Y
12.11.2025
JB Chemicals Standalone September 2025 Net Sales at Rs 1,022.65 crore, up 7% Y-o-Y
12.02.2014
25.03.2026
25.03.2026
25.03.2026
24.03.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth